<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05004103</url>
  </required_header>
  <id_info>
    <org_study_id>CRSU.P.PTI/11/20/17.02</org_study_id>
    <nct_id>NCT05004103</nct_id>
  </id_info>
  <brief_title>Cosmetic Products and Facial Skin Microbiome</brief_title>
  <official_title>The Efficacy of Cosmetic Products and Its Effects on Facial Skin Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PT Paragon Technology and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The skin microbiome diversity in female healthy volunteers will be studied along with&#xD;
      cosmetic products application in 1 month period. This study is also aimed to investigate the&#xD;
      efficacy of cosmetic products on skin rejuvenation. .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is conducted in COVID-19 pandemic era, thus every person involved in this study&#xD;
      must follow health protocol for COVID-19.&#xD;
&#xD;
      The study procedure, consist of screening visit (D -7), 7-day wash out, baseline visit (D 0),&#xD;
      first follow up ( D 14), and second follow up (D 28).&#xD;
&#xD;
        1. Screening visit: obtained Informed Consent, COVID-19 detection by swab RT-PCR, and&#xD;
           inclusion and exclusion criteria, wash out product dispensing, and subject's diary&#xD;
           dispensing.&#xD;
&#xD;
        2. Baseline visit: Investigator will check vital signs, facial skin value by Cutometer,&#xD;
           Mexameter, Sebumeter, Corneometer, Colorimeter, Tewameter, dan pH meter, and kin taping&#xD;
           by Corneofix tape. Investigational Products will dispensed in this visit for 2 weeks&#xD;
           usage.&#xD;
&#xD;
        3. First follow up: Investigator will check vital signs and facial skin value.&#xD;
           Investigational Products will dispensed in this visit for 2 weeks usage.&#xD;
&#xD;
        4. Second follow up: Investigator will check vital signs, facial skin value, and skin&#xD;
           taping by Corneofix tape.&#xD;
&#xD;
      All adverse events (AEs) occurred during study will be recorded in Case Report Form.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">August 20, 2021</completion_date>
  <primary_completion_date type="Actual">May 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Pre-post study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiome diversity index</measure>
    <time_frame>28 days</time_frame>
    <description>The amount and diversity of microbiota will be observed on facial skin before and after product application</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Facial skin elasticity</measure>
    <time_frame>28 days</time_frame>
    <description>The ratio between pliability/firmness and expressed in mm. The result before and after product application will be observed by cutometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sebum unit of facial skin</measure>
    <time_frame>28 days</time_frame>
    <description>Sebumeter unit (mcg/cm2) of facial skin before and after product application will be observed using sebumeter. This sebumeter unit reflects the concentration of sebum on skin per observed area.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Capacity of corneometer unit</measure>
    <time_frame>28 days</time_frame>
    <description>Corneometer unit reflects the moist index of skin. The corneometer unit observed by Corneometer, before and after product application.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin color intensity</measure>
    <time_frame>28 dyas</time_frame>
    <description>The skin color expressed in colorimeter index value. The observation is conducted before and after product application</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transepidermal Waterloss (g/h/m2)</measure>
    <time_frame>28 days</time_frame>
    <description>The hydration of skin is observed by Tewameter. The observation is conducted before and after product application</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pH of facial skin</measure>
    <time_frame>28 days</time_frame>
    <description>The pH of facial skin is observed using skin-pH-meter. Observation is conducted before and after product application</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The skin color related to the Minimal Erythema Dosage (MED)</measure>
    <time_frame>28 Days</time_frame>
    <description>The skin color (MED) is observed using Mexameter and is conducted before and after product application</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Cosmetics Product Effects</condition>
  <arm_group>
    <arm_group_label>Skin microbiome evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Female healthy volunteers applied cosmetic products (cleanser and moisturizer cream), the diversity of skin microbiome will be examined before and after using the products</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cosmetic products application</intervention_name>
    <description>Female healthy volunteers applied cosmetic products (cleanser and moisturizer) in the morning and afternoon for 1 month. Seven days wash out period will be conducted prior study starts. The evaluation will be conducted before, two weeks after treatment starts, and at the end of the study.</description>
    <arm_group_label>Skin microbiome evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. female 18-35 years old&#xD;
&#xD;
          2. signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. infected by COVID-19&#xD;
&#xD;
          2. females with skin diseases on face and neck such as atopic dermatitis, skin allergy,&#xD;
             acne with moderate and severe degree, seborrheic dermatitis, malignancy&#xD;
&#xD;
          3. females with ongoing skin treatments.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Healthy females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frans Suyatna, Prof, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Supporting Unit, Faculty of Medicine, University of Indonesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Supporting Unit</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Collins-Fulea C, Klima K, Wegienka GR. Prevalence of low vitamin D levels in an urban midwestern obstetric practice. J Midwifery Womens Health. 2012 Sep-Oct;57(5):439-44. doi: 10.1111/j.1542-2011.2012.00167.x.</citation>
    <PMID>22954074</PMID>
  </reference>
  <reference>
    <citation>Vijay A, Gupta S, Rawat S, Jain SK. A Rare Case of Coinfection with White Piedra and Pediculosis Capitis. Indian Dermatol Online J. 2017 Jul-Aug;8(4):279-280. doi: 10.4103/idoj.IDOJ_353_16.</citation>
    <PMID>28761849</PMID>
  </reference>
  <reference>
    <citation>Wallen-Russell, C. The Role of Every-Day Cosmetics in Altering the Skin Microbiome: A Study Using Biodiversity. Cosmetics 2019, 6, 2. https://doi.org/10.3390/cosmetics6010002</citation>
  </reference>
  <results_reference>
    <citation>Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018 Mar;16(3):143-155. doi: 10.1038/nrmicro.2017.157. Epub 2018 Jan 15. Review.</citation>
    <PMID>29332945</PMID>
  </results_reference>
  <results_reference>
    <citation>Ogai K, Nagase S, Mukai K, Iuchi T, Mori Y, Matsue M, Sugitani K, Sugama J, Okamoto S. A Comparison of Techniques for Collecting Skin Microbiome Samples: Swabbing Versus Tape-Stripping. Front Microbiol. 2018 Oct 2;9:2362. doi: 10.3389/fmicb.2018.02362. eCollection 2018. Erratum in: Front Microbiol. 2018 Nov 20;9:2812.</citation>
    <PMID>30333815</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee HJ, Jeong SE, Lee S, Kim S, Han H, Jeon CO. Effects of cosmetics on the skin microbiome of facial cheeks with different hydration levels. Microbiologyopen. 2018 Apr;7(2):e00557. doi: 10.1002/mbo3.557. Epub 2017 Nov 29.</citation>
    <PMID>29193830</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Prof. dr. Franciscus D. Suyatna, PhD, SpFK</investigator_full_name>
    <investigator_title>Clinical Pharmacology Professor</investigator_title>
  </responsible_party>
  <keyword>Skin Microbiome</keyword>
  <keyword>Facial Skin Microbiome</keyword>
  <keyword>MIcrobiome diversity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

